Clinical Chemistry and Immunoassay Industry, Global, 2023?2028
Integrated and Scalable Core Lab Solutions Driving Transformational Growth
30-Oct-2024
Global
Market Research
PFPY-01-00-00-00
HC_2024_1106
This analysis examines the global clinical chemistry and immunoassay sector, accounting for the highest share in the in vitro diagnostics (IVD) market. This type of lab-based testing analyzes body fluids (usually blood, urine, or saliva) using integrated/standalone analyzers and a wide range of assays/panels, among other solutions and services to support the diagnosis and treatment of human health.
While clinical chemistry instruments and tests target different chemicals in body fluids to evaluate health and the clinical management of patients, immunoassay instruments and tests measure the presence or concentration of analytes in biological liquid by using the binding of antibodies to antigens to identify and measure certain substances. This competitive analysis examines IVD companies that provide a broad menu of clinical chemistry and immunoassay systems, including instruments and consumables. Key end-user verticals comprise hospitals, clinics, diagnostic laboratories, and research institutions. The sector is segmented by applications, including cancer/oncology, cardiac, diabetes, infectious, and others, for market revenue estimations and forecasts. The study also identifies four growth opportunities that build on trends, maximize the economic potential, and sustain value.
Author: Amartya Bose
Scope of Analysis
Segmentation
Why Is It Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Clinical Chemistry and Immunoassay Industry
Competitive Environment
Key Competitors
Growth Metrics
Growth Drivers
Growth Drivers (continued)
Growth Restraints
Forecast Considerations
Revenue Forecast
Revenue Forecast by Application Areas
Revenue Forecast by Region
Revenue Forecast Analysis
Pricing Trends and Forecast Analysis
Revenue Share
Revenue Share Analysis
Revenue Share Analysis (continued)
Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Forecast Analysis
Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Forecast Analysis
Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Forecast Analysis
Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Forecast Analysis
Growth Metrics
Revenue Forecast
Revenue Forecast by Region
Forecast Analysis
Growth Opportunity 1: Sepsis IVDs
Growth Opportunity 1: Sepsis IVDs (continued)
Growth Opportunity 2: Neurology IVDs
Growth Opportunity 2: Neurology IVDs (continued)
Growth Opportunity 3: Routine Testing
Growth Opportunity 3: Routine Testing (continued)
Growth Opportunity 4: Integrated Analyzers
Growth Opportunity 4: Integrated Analyzers (continued)
Benefits and Impacts of Growth Opportunities
Next Steps
List of Exhibits
List of Exhibits (continued)
Legal Disclaimer
- Clinical Chemistry and Immunoassay: Growth Metrics, Global, 2023‒2028
- Clinical Chemistry and Immunoassay: Growth Drivers, Global, 2024-2028
- Clinical Chemistry and Immunoassay: Growth Restraints, Global, 2024-2028
- Clinical Chemistry and Immunoassay: Revenue Forecast, Global, 2023‒2028
- Clinical Chemistry and Immunoassay: Revenue Forecast by Application Areas, Global, 2023-2028
- Clinical Chemistry and Immunoassay: Revenue Forecast by Region, 2023-2028
- Clinical Chemistry and Immunoassay: Revenue Share of Top Participants, Global, 2023
- Cancer: Growth Metrics, Global, 2023
- Cancer: Revenue Forecast, Global, 2023-2028
- Cancer: Revenue Forecast by Region, 2023-2028
- Cardiac: Growth Metrics, Global, 2023
- Cardiac: Revenue Forecast, Global, 2023-2028
- Cardiac: Revenue Forecast by Region, 2023-2028
- Diabetes: Growth Metrics, Global, 2023
- Diabetes: Revenue Forecast, Global, 2023-2028
- Diabetes: Revenue Forecast by Region, 2023-2028
- Infectious Diseases: Growth Metrics, Global, 2023-2028
- Infectious Diseases: Revenue Forecast, Global, 2023-2028
- Infectious Diseases: Revenue Forecast by Region, 2023-2028
- Others: Growth Metrics, Global, 2023-2028
- Others: Revenue Forecast, Global, 2023-2028
- Others: Revenue Forecast by Region, 2023-2028
Speak directly with our analytics experts for tailored recommendations.
Recent related Healthcare research
17 Nov 2026 | Global | Frost Radar
Frost Radar™: Quantum-Grade Sensor Technology Ecosystem for Healthcare Applications, 2026
Quantum-grade sensors are advancing healthcare by leveraging quantum phenomena to enable highly sensitive, precise, and non-invasive measurements of biological signals and physiological parameters. These innovations enhance diagnostic accuracy, disease monitoring, brain activity measurement, and ear...
16 Nov 2026 | North America | Frost Radar
Frost Radar™: Healthcare Data Interoperability Platforms and Integration Engines in North America, 2026
This Frost Radar™ analyzes the healthcare data platform and integration engine vendors that enable healthcare organization to improve the exchange, utilization, contextualization, and management of clinical, operational, financial, and administrative data. Data issues, AI adoption, and solution gove...
03 Nov 2026 | North America | Market Research
Enterprise Imaging Market, United States, 2025–2030
Enterprise imaging is no longer a technology upgrade. It is becoming the operating model for imaging across the provider organization, and the next investment cycle will decide which vendors lead it. This study gives vendors, ecosystem partners, and provider leaders a 360-degree view of that shift, ...
02 Nov 2026 | Global | Market Research
Continuous Glucose Monitoring Market, Global, 2026
The global continuous glucose monitoring (CGM) market is undergoing a fundamental transformation as the technology evolves from a prescription-led glucose monitoring device into an AI-connected metabolic intelligence ecosystem. Market expansion is increasingly driven by the emergence of over-the-cou...
28 Oct 2026 | Global | Frost Radar
Frost Radar™: Health Monitoring Wearable Solutions, 2026
The health monitoring wearables industry is undergoing a profound transformation as competitive advantage shifts from device hardware to integrated digital health ecosystems. Market leaders are differentiating through clinically validated health insights, longitudinal data platforms, AI-enabled anal...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.